These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 19924373)
1. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: hepatocellular carcinoma: imaging in assessing treatment efficacy. Vilgrain V J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):374-9. PubMed ID: 19924373 [TBL] [Abstract][Full Text] [Related]
2. Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments: imaging diagnosis and staging of hepatocellular carcinoma. Choi BI; Lee JM J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):369-73. PubMed ID: 19967573 [TBL] [Abstract][Full Text] [Related]
3. Assessment of the treatment response of HCC. Kim KW; Lee JM; Choi BI Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353 [TBL] [Abstract][Full Text] [Related]
4. Current approach to hepatocellular carcinoma. Abrams P; Marsh JW Surg Clin North Am; 2010 Aug; 90(4):803-16. PubMed ID: 20637949 [TBL] [Abstract][Full Text] [Related]
5. Recent advances in the treatment of hepatocellular carcinoma. Padhya KT; Marrero JA; Singal AG Curr Opin Gastroenterol; 2013 May; 29(3):285-92. PubMed ID: 23507917 [TBL] [Abstract][Full Text] [Related]
6. [Imaging features and evaluation of liver lesions after non-surgical therapy]. Delumeau S; Lebigot J; Ridereau-Zins C; Bouvier A; Boursier J; Aubé C J Radiol; 2011; 92(7-8):632-58. PubMed ID: 21819907 [TBL] [Abstract][Full Text] [Related]
7. Management of hepatocellular carcinoma in the age of liver transplantation. Martin AP Int J Surg; 2009 Aug; 7(4):324-9. PubMed ID: 19643691 [TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation combined with chemoembolization: treatment of recurrent hepatocellular carcinomas after hepatectomy. Takaki H; Yamakado K; Sakurai H; Nakatsuka A; Shiraki K; Isaji S; Takeda K AJR Am J Roentgenol; 2011 Aug; 197(2):488-94. PubMed ID: 21785099 [TBL] [Abstract][Full Text] [Related]
17. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer. Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641 [TBL] [Abstract][Full Text] [Related]
18. Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective. Colombo M; Raoul JL; Lencioni R; Galle PR; Zucman-Rossi J; Bañares R; Seehofer D; Neuhaus P; Johnson P Eur J Gastroenterol Hepatol; 2013 Jun; 25(6):639-51. PubMed ID: 23628963 [TBL] [Abstract][Full Text] [Related]
19. Management of HCC. de Lope CR; Tremosini S; Forner A; Reig M; Bruix J J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468 [TBL] [Abstract][Full Text] [Related]
20. Evidence-based diagnosis and locoregional therapy for hepatocellular carcinoma. Pleguezuelo M; Germani G; Marelli L; Xiruochakis E; Misseri M; Manousou P; Arvaniti V; Burroughs AK Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):761-84. PubMed ID: 19090737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]